HomeCLBT • NASDAQ
Cellebrite DI Ltd
$10.41
After Hours:
$10.37
(0.38%)-0.040
Closed: Jun 4, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$10.44
Day range
$10.25 - $10.50
Year range
$5.51 - $12.50
Market cap
2.14B USD
Avg Volume
793.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
(USD)Mar 2024Y/Y change
Revenue
86.01M25.91%
Operating expense
67.07M14.28%
Net income
-71.37M-75.77%
Net profit margin
-82.98-39.60%
Earnings per share
0.08166.67%
EBITDA
11.45M332.84%
Effective tax rate
-2.95%
Total assets
Total liabilities
(USD)Mar 2024Y/Y change
Cash and short-term investments
276.55M36.47%
Total assets
529.14M28.22%
Total liabilities
555.84M48.89%
Total equity
-26.71M
Shares outstanding
196.82M
Price to book
-74.57
Return on assets
4.13%
Return on capital
126.84%
Net change in cash
(USD)Mar 2024Y/Y change
Net income
-71.37M-75.77%
Cash from operations
10.04M-19.52%
Cash from investing
-81.60M-1,907.75%
Cash from financing
5.07M85.68%
Net change in cash
-67.08M-692.26%
Free cash flow
-44.49M-172.06%
About
Cellebrite DI Ltd. is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data. On April 8, 2021, Cellebrite announced plans to go public via a merger with a blank-check firm, valuing the company at approximately $2.4 billion. Their flagship product series is the Cellebrite UFED. Wikipedia
Founded
1999
Employees
1,008
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu